Enlivex Therapeutics Ltd. (ENLV) Earnings
|
Expand Research on ENLV
| Next EPS Date | 12/7/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +46.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
12/7/26  |
Q326 | N/A | -$0.28 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/28/26 |
Q226 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/26/26 |
Q226 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/24/26 |
Q226 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/31/26 |
Q226 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/26/26 |
Q126 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/25/26 |
Q126 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/22/26 |
Q126 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A |
